Stephan Dupke
Overview
Explore the profile of Stephan Dupke including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
138
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Post G, Shalev N, Baumgarten A, Shimakawa Y, Lemoine M, Krznaric I, et al.
Eur J Gastroenterol Hepatol
. 2019 Apr;
31(6):723-728.
PMID: 30964812
Background And Aims: The prevalence of chronic hepatitis B virus (HBV) infection in Europe is poorly defined. Data on the proportion of patients eligible for therapy are lacking but are...
2.
Jansen K, Thamm M, Bock C, Scheufele R, Kucherer C, Muenstermann D, et al.
PLoS One
. 2015 Nov;
10(11):e0142515.
PMID: 26555244
Objectives: Men who have sex with men (MSM) are at higher risk for coinfection with hepatitis B virus (HBV), hepatitis C virus (HCV), and syphilis than the general population. HIV...
3.
Ingiliz P, Steininger K, Schuetze M, Dupke S, Carganico A, Krznaric I, et al.
J Int AIDS Soc
. 2014 Nov;
17(4 Suppl 3):19638.
PMID: 25394142
Introduction: Acute hepatitis C virus (HCV) infection has emerged as a major cause of morbidity in the HIV-infected population. Most guidelines recommend early treatment with pegylated interferon and ribavirin due...
4.
Zu Knyphausen F, Scheufele R, Kucherer C, Jansen K, Somogyi S, Dupke S, et al.
PLoS One
. 2014 May;
9(5):e95956.
PMID: 24788613
Background: Transmission of drug-resistant HIV-1 (TDR) can impair the virologic response to antiretroviral combination therapy. Aim of the study was to assess the impact of TDR on treatment success of...
5.
Jansen K, Haastert B, Michalik C, Guignard A, Esser S, Dupke S, et al.
BMC Infect Dis
. 2013 Aug;
13:372.
PMID: 23937603
Background: HIV infection is a risk factor for the development of Herpes zoster (HZ) and its complications. Prior to antiretroviral therapy (ART), HZ incidence in HIV-infected individuals ranged from 2.9-5.1/100...
6.
Jansen K, Sonnerborg A, Brockmeyer N, Thalme A, Svedhem V, Dupke S, et al.
AIDS Res Hum Retroviruses
. 2012 Sep;
29(3):564-73.
PMID: 23016535
Atazanavir-based regimens have established efficacy and safety in both antiretroviral (ARV)-naive and -experienced patients. However, data evaluating effectiveness beyond 2 years is sparse. Therefore, we assessed the long-term outcomes of...
7.
Mostardt S, Hanhoff N, Wasem J, Goetzenich A, Schewe K, Wolf E, et al.
Eur J Health Econ
. 2012 Sep;
14(5):799-808.
PMID: 22990377
Objectives: The aims of this study were to estimate the expenditure for HIV-care in Germany and to identify variables associated with resource use. Design/setting: We performed an 18-month prospective multi-center...
8.
Bartmeyer B, Kuecherer C, Houareau C, Werning J, Keeren K, Somogyi S, et al.
PLoS One
. 2010 Oct;
5(10):e12718.
PMID: 20949104
Background: The aim of this study is to analyse the prevalence of transmitted drug resistance, TDR, and the impact of TDR on treatment success in the German HIV-1 Seroconverter Cohort....
9.
Streeck H, Jessen H, Kuecherer C, Li B, Jessen A, Dupke S, et al.
AIDS
. 2008 Dec;
23(2):259-62.
PMID: 19098497
The diversity of HIV-1 and human genetics complicates our ability to determine the impact of treatment during primary HIV-1 infection on disease outcome. Here, we show, in a small group...
10.
Loschen S, Batzing-Feigenbaum J, Poggensee G, Cordes C, Hintsche B, Rausch M, et al.
J Clin Microbiol
. 2007 Nov;
46(1):341-5.
PMID: 17977990
The sensitivity and specificity of the human immunodeficiency virus (HIV) type 1-specific immunoglobulin G capture enzyme-linked immunosorbent assay (BED-CEIA) were compared with those of the avidity index method to identify...